[1] YU S, ZHANG X, LI W, et al. Thermosensitive hydrogel as a sustained release carrier for mesenchymal stem cell-derived extracellular vesicles in the treatment of intrauterine adhesion. J Nanobiotechnology. 2024;22(1):570.
[2] LEE WL, LIU CH, CHENG M, et al. Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision. Int J Mol Sci. 2021;22(10):5175.
[3] PENG X, WANG T, DAI B, et al. Gene Therapy for Inflammatory Cascade in Intrauterine Injury with Engineered Extracellular Vesicles Hybrid Snail Mucus-enhanced Adhesive Hydrogels. Adv Sci (Weinh). 2025;12(1):e2410769.
[4] XIN L, WEI C, TONG X, et al. In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: A therapy for intrauterine adhesions. Bioact Mater. 2021;12:107-119.
[5] CAO Y, WU J, HUANG J, et al. Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats. Stem Cell Res Ther. 2025;16(1):204.
[6] CHEN P, YE C, HUANG Y, et al. Glutaminolysis regulates endometrial fibrosis in intrauterine adhesion via modulating mitochondrial function. Biol Res. 2024; 57(1):13.
[7] DEANS R, ABBOTT J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555-569.
[8] ZHENG X, HUANG R, YIN L, et al. Injectable antioxidant hyaluronan/chitosan hydrogel as a platelet-rich plasma and stem cell carrier to promote endometrial regeneration and fertility restoration. Acta Biomater. 2025;195:201-215.
[9] LIU Y, JIA D, LI L, et al. Advances in Nanomedicine and Biomaterials for Endometrial Regeneration: A Comprehensive Review. Int J Nanomedicine. 2024;19:8285-8308.
[10] XIONG Z, HU Y, JIANG M, et al. Hypoxic bone marrow mesenchymal stem cell exosomes promote angiogenesis and enhance endometrial injury repair through the miR-424-5p-mediated DLL4/Notch signaling pathway. PeerJ. 2024;12:e16953.
[11] YU D, WONG YM, CHEONG Y, et al. Asherman syndrome--one century later. Fertil Steril. 2008;89(4):759-779.
[12] GAO M, YU Z, YAO D, et al. Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure. Tissue Cell. 2022;74:101676.
[13] GÓRNICKI T, JÓZKOWIAK M, DATA K, et al. Wharton’s jelly mesenchymal stem cells (WJ-MSCs), a “Holy Grail” in tissue bioengineering and reconstructive medicine. Biomed Pharmacother. 2025;192:118570.
[14] KOISHYBAYEVA D, AMIRASHOV A, BALMAGAMBETOVA S, et al. Mesenchymal stem cell therapy for diabetes: An umbrella review. Tissue Cell. 2025;96:103043.
[15] YI X, LIU F, GAO K, et al. Reconstructable Uterus-Derived Materials for Uterus Recovery toward Efficient Live Births. Adv Mater. 2022;34(8):e2106510.
[16] CAO Y, SUN H, ZHU H, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9(1):192.
[17] YU X, SHI L, ZHANG Y, et al. A Comparative Study of Mesenchymal Stem Cells from Various Sources in Endometrial Repair: the Significant Advantages of Decidual Mesenchymal Stem Cells. Stem Cell Rev Rep. 2025;21(8):2667-2670.
[18] LI Q, LIAO Z, HU X, et al. Phase 1 dose-escalation trial of sub-endometrial injection of human embryonic stem cells-derived immunity-and-matrix-regulatory cells to promote endometrial angiogenesis in refractory intrauterine adhesion. Mol Ther. 2026;34(1):423-442.
[19] LIANG Y, SHUAI Q, ZHANG X, et al. Incorporation of Decidual Stromal Cells Derived Exosomes in Sodium Alginate Hydrogel as an Innovative Therapeutic Strategy for Advancing Endometrial Regeneration and Reinstating Fertility. Adv Healthc Mater. 2024;13(13):e2303674.
[20] TAN F, LI X, WANG Z, et al. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17.
[21] LI B, CAO Y, SUN M, et al. Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. FASEB J. 2021;35(10):e21916.
[22] KALLURI R, LEBLEU VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
[23] KARIM RONY RMI, TOMPKINS JD. Cardiac repair and regeneration: cell therapy, in vivo reprogramming, and the promise of extracellular vesicles. Exp Mol Med. 2025;57(10):2182-2200.
[24] SONG J, LIU J, CUI C, et al. Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK/ULK1-mediated autophagy. J Cachexia Sarcopenia Muscle. 2023;14(2):915-929.
[25] NAZDIKBIN YAMCHI N, AHMADIAN S, MOBARAK H, et al. Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway. J Ovarian Res. 2023;16(1):118.
[26] PARK HS, CETIN E, SIBLINI H, et al. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS. Int J Mol Sci. 2023;24(13):11151.
[27] ZHANG H, FANG Y, GAO Y, et al. Brown adipose tissue-derived exosomes delay fertility decline in aging mice. Front Endocrinol (Lausanne). 2023;14:1180104.
[28] LIAO Z, LIU C, WANG L, et al. Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases. Front Endocrinol (Lausanne). 2021;12:665645.
[29] LIU HD, WANG SW. Role of noncoding RNA in the pathophysiology and treatment of intrauterine adhesion. Front Genet. 2022;13:948628.
[30] SUN D, JIANG Z, CHEN Y, et al. MiR-455-5p upregulation in umbilical cord mesenchymal stem cells attenuates endometrial injury and promotes repair of damaged endometrium via Janus kinase/signal transducer and activator of transcription 3 signaling. Bioengineered. 2021;12(2):12891-12904.
[31] CHEN JM, HUANG QY, CHEN WH, et al. Transcriptomics of tissue exosomes to investigate miR-195-5p’s amelioration of endometrial fibrosis via the YAP-Smad7 pathway: an animal study. J Transl Med. 2024;22(1):1050.
[32] LI X, DUAN H, WANG S, et al. Umbilical cord mesenchymal stem cell-derived exosomes reverse endometrial fibrosis by the miR-145-5p/ZEB2 axis in intrauterine adhesions. Reprod Biomed Online. 2023;46(2):234-243.
[33] SHAO X, QIN J, WAN C, et al. ADSC Exosomes Mediate lncRNA-MIAT Alleviation of Endometrial Fibrosis by Regulating miR-150-5p. Front Genet. 2021;12:679643.
[34] CHEN S, MA Y, QIU X, et al. MicroRNA-122-5p alleviates endometrial fibrosis via inhibiting the TGF-β/SMAD pathway in Asherman’s syndrome. Reprod Biomed Online. 2023;47(5):103253.
[35] ZHANG H, XING J, SUN M, et al. Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis. Biomaterials. 2026;324:123510.
[36] IQBAL Z, REHMAN K, MAHMOOD A, et al. Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnology. 2024;22(1):395.
[37] AAGL ADVANCING MINIMALLY INVASIVE GYNECOLOGY WORLDWIDE. AAGL practice report: practice guidelines for management of intrauterine synechiae. J Minim Invasive Gynecol. 2010;17(1):1-7.
[38] 杨玉伟,李万里,陈继冰,等.间充质干细胞包裹人胰岛减轻即刻经血液介导的炎症反应的体外研究 [J].器官移植,2023,14(4):562-569.
[39] LI J, PAN Y, YANG J, et al. Tumor necrosis factor-α-primed mesenchymal stem cell-derived exosomes promote M2 macrophage polarization via Galectin-1 and modify intrauterine adhesion on a novel murine model. Front Immunol. 2022;13:945234.
[40] CHEN TQ, WEI XJ, LIU HY, et al. Telocyte-Derived Exosomes Provide an Important Source of Wnts That Inhibits Fibrosis and Supports Regeneration and Repair of Endometrium. Cell Transplant. 2023;32:9636897231212746.
[41] SUN W, XU W, XIAO M, et al. Enhancing exosome stability and delivery with natural polymers to prevent intrauterine adhesions and promote endometrial regeneration: a review. J Nanobiotechnology. 2025;23(1):529.
[42] LIN Y, LI Y, CHEN P, et al. Exosome-Based Regimen Rescues Endometrial Fibrosis in Intrauterine Adhesions Via Targeting Clinical Fibrosis Biomarkers. Stem Cells Transl Med. 2023;12(3):154-168.
[43] QIN Z, YU Q, LONG Y. Unveiling the Pathological Landscape of Intrauterine Adhesion: Mechanistic Insights and Exosome-Biomaterial Therapeutic Innovations. Int J Nanomedicine. 2025;20:9667-9694.
[44] ZHOU Z, WANG H, ZHANG X, et al. Defective autophagy contributes to endometrial epithelial-mesenchymal transition in intrauterine adhesions. Autophagy. 2022;18(10):2427-2442.
[45] ZHAI X, PU D, WANG R, et al. Gas6/AXL pathway: immunological landscape and therapeutic potential. Front Oncol. 2023;13:1121130.
[46] ZHOU L, DONG L, LI H, et al. Mesenchymal stem cell-derived exosomes ameliorate TGF-β1-induced endometrial fibrosis by altering their miRNA profile. Am J Transl Res. 2023;15(5):3203-3216.
[47] ZHANG Z, HU J. DKK1 loss promotes endometrial fibrosis via autophagy and exosome-mediated macrophage-to-myofibroblast transition. J Transl Med. 2024;22(1):617.
[48] LIANG Y, MENG J, YU Z, et al. Ru single-atom nanozymes targeting ROS-ferroptosis pathways for enhanced endometrial regeneration in intrauterine adhesion therapy. Biomaterials. 2025;315:122923.
[49] SONG M, MA L, ZHU Y, et al. Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis. Sci Rep. 2024;14(1):8321.
[50] YUAN D, GUO T, QIAN H, et al. Exosomal miR-543 derived from umbilical cord mesenchymal stem cells ameliorates endometrial fibrosis in intrauterine adhesion via downregulating N-cadherin. Placenta. 2023;131:75-81.
[51] WANG S, LIU T, NAN N, et al. Exosomes from Human Umbilical Cord Mesenchymal Stem Cells Facilitates Injured Endometrial Restoring in Early Repair Period through miR-202-3p Mediating Formation of ECM. Stem Cell Rev Rep. 2023;19(6): 1954-1964.
[52] XIAO B, ZHU Y, LIU M, et al. miR-340-3p-modified bone marrow mesenchymal stem cell-derived exosomes inhibit ferroptosis through METTL3-mediated m6A modification of HMOX1 to promote recovery of injured rat uterus. Stem Cell Res Ther. 2024;15(1):224.
[53] LU W, GUO Y, LIU H, et al. The Inhibition of Fibrosis and Inflammation in Obstructive Kidney Injury via the miR-122-5p/SOX2 Axis Using USC-Exos. Biomater Res. 2024;28:0013.
[54] CABALLERO-VALDERRAMA MR, BEVILACQUA E, ECHEVARRÍA M, et al. Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity. Biomedicines. 2024;13(1):45.
[55] LI B, LI Y, LI S, et al. Circ_MTM1 knockdown inhibits the progression of HBV-related liver fibrosis via regulating IL7R expression through targeting miR-122-5p. Am J Transl Res. 2022;14(4):2199-2211.
[56] YAO S, ZHOU Z, WANG L, et al. Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH. iScience. 2023;26(7):107201.
[57] XI J, PAN Y, JIN C, et al. Evaluation of different rat models intrauterine adhesion models and improvement of the technique for their establishment. Exp Anim. 2023;72(2):274-284. |